Cetuximab plus FOLFIRINOX (ERBIRINOX) as first-line treatment for unresectable metastatic colorectal cancer: a phase II trial
西妥昔单抗联合FOLFIRINOX（ERBIRINOX）方案作为不可切除转移性结直肠癌的一线治疗：一项II期试验
期刊:Oncologist
影响因子:4.2
doi:10.1634/theoncologist.2011-0141
Assenat, Eric; Desseigne, Francoise; Thezenas, Simon; Viret, Frédéric; Mineur, Laurent; Kramar, Andrew; Samalin, Emmanuelle; Portales, Fabienne; Bibeau, Frédéric; Crapez-Lopez, Evelyne; Bleuse, Jean Pierre; Ychou, Marc
